Martijn Figee, MD, PhD
- ASSOCIATE PROFESSOR | Psychiatry
- ASSOCIATE PROFESSOR | Neurosurgery
Dr. Figee is a psychiatrist and associate professor of Psychiatry, Neurosurgery, Neurology and Neuroscience working at the Nash Family Center for Advanced Circuit Therapeutics (C-ACT). Dr. Figee is director of the Mount Sinai Interventional Psychiatry Program, focusing on the psychiatric application and study of neuromodulation, in particular deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS). He received his medical degree, residency and PhD from the University of Amsterdam.
His research focuses on the role of reward and mood circuits in neuropsychiatric disorders, such as obsessive-compulsive disorder (OCD), depression and Parkinson’s disease, and how these circuits can be modulated with DBS. He pioneered the first application of fMRI in DBS-implanted individuals. He has published numerous scientific articles and book chapters on DBS for psychiatry. Dr. Figee aims to progress DBS and other types of neuromodulation as neuropsychiatric interventions, by investigating its effects on cross-diagnostic outcomes and associated neural networks.
- Deep Brain Stimulation
- Obsessive-compulsive disorder
- Major depressive disorder
- Tourette Syndrome
- Parkinson’s Disease
- Tardive and primary dystonia
- Mount Sinai West
- The Mount Sinai Hospital
- Center for Neuromodulation at Mount Sinai West 212-523-8340
For new appointments with Dr. Figee, please complete our intake form.
MD, Academic Medical Center, University of Amsterdam
MD, University of Amsterdam, Academic Medical Center
Residency, Kings College, Institute of Psychiatry
Residency, University of Amsterdam, Academic Medical Center
Residency, Clinical Psychiatry, University of Amsterdam, AMC Dept. of Psychiatry
Residency, Clinical Psychiatry, Kings College, Institute of Psychiatry
Residency, Clinical Psychiatry, Academic Medical Center
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Figee during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- University Medical Center Utrecht
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.